- Previous Close
68.74 - Open
69.30 - Bid --
- Ask --
- Day's Range
65.25 - 69.33 - 52 Week Range
59.24 - 115.95 - Volume
880,768 - Avg. Volume
885,418 - Market Cap (intraday)
16.724B - Beta (5Y Monthly) -0.08
- PE Ratio (TTM)
-- - EPS (TTM)
-1.91 - Earnings Date Feb 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 20, 2023
- 1y Target Est
--
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil. In addition, the company provides herbicides, such as triclopyr butoxy ethyl ester, as well as 2,4-D acid tech, sodium salt WP/SP, and EsterTech; intermediates, including cypermethric acid chloride, meta phenoxy benzaldehyde, meta phenoxy benzyl alcohol, monochloroacetic acid, high trans cypermethric acid chloride, and high cis cypermethric acid chloride. Further, it offers technical and formulations that are used in crop protection, veterinary, and public health applications. Additionally, the company offers anatase and rutile grade titanium dioxide for the use in paints, coatings, plastics, polymers, inks, dyes, paper, and cosmetics. Meghmani Organics Limited was founded in 1986 and is based in Ahmedabad, India.
meghmani.com1,720
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: MOL.NS
View MorePerformance Overview: MOL.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MOL.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MOL.NS
View MoreValuation Measures
Market Cap
16.72B
Enterprise Value
23.65B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.87
Price/Book (mrq)
1.11
Enterprise Value/Revenue
1.23
Enterprise Value/EBITDA
21.77
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.50%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
19.36B
Net Income Avi to Common (ttm)
-483.81M
Diluted EPS (ttm)
-1.91
Balance Sheet and Cash Flow
Total Cash (mrq)
327.8M
Total Debt/Equity (mrq)
53.24%
Levered Free Cash Flow (ttm)
--